Published in Virus Res on July 01, 1985
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol (1987) 2.89
Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol (1990) 2.73
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol (1988) 1.92
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Identification and characterization of a serine-like proteinase of the murine coronavirus MHV-A59. J Virol (1995) 1.76
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis. EMBO J (2001) 1.75
Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J Virol (1994) 1.72
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication. J Virol (1992) 1.61
Flock house virus: down-regulation of subgenomic RNA3 synthesis does not involve coat protein and is targeted to synthesis of its positive strand. J Virol (1993) 1.41
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Differential premature termination of transcription as a proposed mechanism for the regulation of coronavirus gene expression. Nucleic Acids Res (1988) 1.40
Discontinuous and non-discontinuous subgenomic RNA transcription in a nidovirus. EMBO J (2002) 1.32
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59. J Virol (1991) 1.19
RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol (1988) 1.19
RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A (1987) 1.11
Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J Virol (1992) 1.07
RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments. J Virol (1992) 1.03
Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J Virol (1995) 0.93
Genome organization of the SARS-CoV. Genomics Proteomics Bioinformatics (2003) 0.75
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med (1999) 4.33
RNA of mouse hepatitis virus. J Virol (1978) 4.27
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Coronavirus genome structure and replication. Curr Top Microbiol Immunol (2005) 2.74
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J Virol (2000) 2.35
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol (2000) 2.16
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol (1999) 2.02
A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am J Trop Med Hyg (1994) 2.01
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. Science (1984) 2.00
Host cell nuclear function and murine hepatitis virus replication. J Gen Virol (1981) 2.00
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol (1988) 1.92
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Management of misplaced or migrated endovascular stents. J Vasc Interv Radiol (1999) 1.82
Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology (1990) 1.79
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol (1992) 1.75
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74
Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol (1993) 1.74
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J Virol (1994) 1.72
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Traumatic thoracic aortic aneurysm: treatment with endovascular stent-grafts. Radiology (1997) 1.70
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol (1990) 1.70
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A (1979) 1.68
Phosphoproteins of Rous sarcoma viruses. Virology (1976) 1.67
Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells. J Virol (1999) 1.67
Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells. Virology (1972) 1.67
Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology (1989) 1.66
Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64
Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol (1993) 1.64
Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol (1994) 1.64
Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology (1998) 1.63
Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol (1992) 1.63
Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62